IL6 and cancer: For example, suramin, an antagonist of the IL-6 receptor, markedly decreased the rate of cachexia in mice with C26 tumors [22], while neutralizing antibodies against IL-6 decreased muscle wasting muscle in rats with cancer cachexia [23].